MARIAM SAAD: Open Payments
NPI 1861071722 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 7 payments from 6 companies in 2025. Trend: 2023 $439 · 2024 $172 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $51 |
| GENZYME CORPORATION | 1 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $33 |
| Incyte Corporation | 1 | $29 |
| Botanix SB Inc | 1 | $17 |
Products named: DUPIXENT, Otezla, SKYRIZI, OPZELURA, SOFDRA.
Industry payments across CA — which companies pay providers there.
